摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate;(5S)-1-methyl-5-pyridin-1-ium-3-ylpyrrolidine-2-thione | 1565854-09-2

中文名称
——
中文别名
——
英文名称
(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate;(5S)-1-methyl-5-pyridin-1-ium-3-ylpyrrolidine-2-thione
英文别名
——
(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate;(5S)-1-methyl-5-pyridin-1-ium-3-ylpyrrolidine-2-thione化学式
CAS
1565854-09-2
化学式
C10H12N2S*C24H40O3
mdl
——
分子量
568.864
InChiKey
AYWUKFAPSHPWDB-RBCUVDQFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.68
  • 重原子数:
    40
  • 可旋转键数:
    5
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    106
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and haemolytic activity of novel salts made of nicotine alkaloids and bile acids
    作者:Beata Jasiewicz、Lucyna Mrówczyńska、Karolina Malczewska-Jaskóła
    DOI:10.1016/j.bmcl.2014.01.005
    日期:2014.2
    A series of novel salts made of nicotine alkaloids and bile acids were synthesized and their haemolytic activity was examined in vitro using human erythrocytes. All compounds were characterized by spectroscopic methods. The novel salts show membrane-perturbing properties inducing the erythrocyte shape alterations and haemolysis in dose-dependent manner. Nicotine decreases the membrane interacting potential of bile acids in the novel compounds. The presence of sulfur or selenium atom in the nicotine molecule affects the haemolytic activity of its novel salts depending on the hydrophobicity of bile acids. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多